a new oral bisphosphonate for osteoporosis called Boniva (ibandronate)

December 2004

In 2005 you'll see a new oral bisphosphonate for osteoporosis called Boniva (ibandronate).

It'll be the first one approved for dosing once a MONTH.

Bisphosphonates are good candidates for intermittent dosing. They can remain active in the bone for several weeks or longer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote